Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 23s ribosomal rna of the 50s ribosomal subunit. It is used clinically to prevent and treat infections caused by susceptible organisms in various body sites. After oral administration it is rapidly absorbed and converted in the liver to its active metabolite Clarithromycin. The drug distributes widely in tissues and is eliminated mainly through hepatic metabolism by the enzyme cyp3a4. Its half-life is approximately six hours allowing multiple daily dosing regimens. Pharmacodynamically it exerts a bacteriostatic or bactericidal effect depending on the pathogen and drug concentration. It blocks the translocation step of peptide bond formation preventing elongation of the growing polypeptide chain. This mechanism leads to inhibition of bacterial protein production and ultimately cell death.

Clarithromycin is a broad-spectrum semisynthetic macrolide antibiotic derived from erythromycin. It is used therapeutically to treat a variety of bacterial infections including respiratory tract infections and skin and soft tissue infections. The drug acts by binding to the 50s ribosomal subunit of susceptible bacteria, inhibiting protein synthesis. This interaction prevents the translocation step of translation, leading to bacteriostatic effects that halt bacterial growth. The pharmacodynamic profile of Clarithromycin is characterized by concentration-dependent activity and a post-antibiotic effect that prolongs bacterial suppression. Its major metabolite contributes to sustained antimicrobial activity in vivo. The selective affinity for bacterial ribosomal components spares host cells, allowing therapeutic benefit without direct cytotoxic actions.

Clarithromycin may cause gastrointestinal discomfort such as nausea or diarrhea. Some patients experience headache or dizziness while taking the medication. Skin reactions like rash or itching can occur in rare cases. The drug can affect liver function leading to abnormal test results. Certain heart rhythms may be altered when combined with other medications. Metabolic disturbances such as changes in blood sugar levels have been reported. These effects are generally mild but can vary among individuals.

Clarithromycin is an antibiotic that is commonly used to treat bacterial infections. One frequent side effect is gastrointestinal discomfort such as nausea and diarrhea. Some people experience taste disturbances, including a metallic or bitter sensation. Headache and dizziness are also reported in a notable number of patients. Skin reactions like rash or itching may develop as an allergic response. In rare cases, liver enzyme elevations can occur, which may cause mild jaundice. Central nervous system effects such as insomnia or vivid dreams have been documented. These reactions are generally mild to moderate and often resolve without medical intervention.